Celon Pharma SA Cash Flow Quality Index
Celon Pharma SA cash flow quality index. Celon Pharma SA (CLN) has a Cash Flow Quality Index of -0.03x as of March 2026. Operating cash flow of zł-4.79 Million is below net income of zł162.60 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow to debt ratio of Celon Pharma SA to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Celon Pharma SA (2012–2020)
Cash flow quality index of Celon Pharma SA from 2012 to 2020. Historical Cash Flow Quality Index for Celon Pharma SA across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. See CLN net asset quality score to measure how much of total assets are equity-financed.
Celon Pharma SA Cash Flow Quality Index by Year (2012–2020)
Celon Pharma SA cash flow quality index by year from 2012 to 2020. Year-by-year earnings quality comparison for Celon Pharma SA. For the full cash flow conversion analysis, see Celon Pharma SA operating cash flow efficiency.
| Year | Quality Index | Operating CF (PLN) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 3.30x | zł70.90 Million | zł21.50 Million | ▲ +879.5% |
| 2019 | -0.42x | zł-5.05 Million | zł11.93 Million | ▼ -144.5% |
| 2018 | 0.95x | zł28.24 Million | zł29.70 Million | ▼ -3.7% |
| 2017 | 0.99x | zł25.30 Million | zł25.62 Million | ▲ +80.9% |
| 2016 | 0.55x | zł20.65 Million | zł37.81 Million | ▼ -61.2% |
| 2015 | 1.41x | zł52.37 Million | zł37.18 Million | ▲ +201.9% |
| 2014 | 0.47x | zł24.36 Million | zł52.21 Million | ▼ -0.8% |
| 2013 | 0.47x | zł8.45 Million | zł17.96 Million | ▼ -95.1% |
| 2012 | 9.65x | zł12.87 Million | zł1.33 Million | — |